Fekete S - Search Results

1

Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor Occupancy.

Wesner K, Hiemke C, Bergemann N, Egberts KM, Fekete S, Gerlach M, Havemann-Reinecke U, Lense XM, Riemer TG, Schoretsanitis G, Uhr M, Zernig G, Gründer G, Hart XM. Wesner K, et al. Among authors: fekete s. J Clin Psychiatry. 2023 Jul 19;84(5):22r14626. doi: 10.4088/JCP.22r14626. J Clin Psychiatry. 2023. PMID: 37471567

2

Therapeutic Drug Monitoring in Children and Adolescents Under Pharmacotherapy With Olanzapine in Daily Clinical Practice.

Fekete S, Wewetzer C, Mehler-Wex C, Holtkamp K, Burger R, Reichert S, Taurines R, Romanos M, Gerlach M, Egberts K. Fekete S, et al. Ther Drug Monit. 2017 Jun;39(3):273-281. doi: 10.1097/FTD.0000000000000398. Ther Drug Monit. 2017. PMID: 28383317

3

[Does methylphenidate cause liver damage? An analysis of ad hoc reports to the "Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)"].

Fekete S, Romanos M, Gerlach M. Fekete S, et al. Z Kinder Jugendpsychiatr Psychother. 2018 Jul;46(4):342-348. doi: 10.1024/1422-4917/a000565. Epub 2017 Dec 14. Z Kinder Jugendpsychiatr Psychother. 2018. PMID: 29237323 German.

4

[No title available]

[No authors listed] [No authors listed] PMID: 31393331

5

Fekete S, Hiemke C, Gerlach M. Fekete S, et al. Ther Drug Monit. 2020 Apr;42(2):315-324. doi: 10.1097/FTD.0000000000000685. Ther Drug Monit. 2020. PMID: 32195989

6

Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride.

Fekete S, Egberts K, Preissler T, Wewetzer C, Mehler-Wex C, Romanos M, Gerlach M. Fekete S, et al. Eur J Clin Pharmacol. 2021 Feb;77(2):163-170. doi: 10.1007/s00228-020-03000-0. Epub 2020 Sep 28. Eur J Clin Pharmacol. 2021. PMID: 32986159 Free PMC article.

7

Therapeutic drug monitoring of children and adolescents treated with aripiprazole: observational results from routine patient care.

Egberts K, Reuter-Dang SY, Fekete S, Kulpok C, Mehler-Wex C, Wewetzer C, Karwautz A, Mitterer M, Holtkamp K, Boege I, Burger R, Romanos M, Gerlach M, Taurines R. Egberts K, et al. Among authors: fekete s. J Neural Transm (Vienna). 2020 Dec;127(12):1663-1674. doi: 10.1007/s00702-020-02253-4. Epub 2020 Sep 30. J Neural Transm (Vienna). 2020. PMID: 32997183

8

Relationship Between Amphetamine Concentrations in Saliva and Serum in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.

Wohkittel C, Högger P, Fekete S, Romanos M, Gerlach M. Wohkittel C, et al. Among authors: fekete s. Ther Drug Monit. 2021 Aug 1;43(4):564-569. doi: 10.1097/FTD.0000000000000831. Ther Drug Monit. 2021. PMID: 33149054

9

Dose-Corrected Serum Concentrations and Metabolite to Parent Compound Ratios of Venlafaxine and Risperidone from Childhood to Old Age.

Fekete S, Scherf-Clavel M, Gerlach M, Romanos M, Kittel-Schneider S, Unterecker S, Egberts K. Fekete S, et al. Pharmacopsychiatry. 2021 May;54(3):117-125. doi: 10.1055/a-1302-8108. Epub 2020 Dec 8. Pharmacopsychiatry. 2021. PMID: 33291155

10

Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride.

Fekete S, Egberts K, Preissler T, Wewetzer C, Mehler-Wex C, Romanos M, Gerlach M. Fekete S, et al. Eur J Clin Pharmacol. 2021 Aug;77(8):1257. doi: 10.1007/s00228-021-03159-0. Eur J Clin Pharmacol. 2021. PMID: 34047799 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

435 results

Search Page